ROIS

ROIS is a leading global Contract Development and Manufacturing Organization (CDMO) specializing in the production of sterile injectables and solid forms. Formerly known as ROVI Pharma Industrial Services, the company rebranded to ROIS in 2025 to reflect its evolution into a transatlantic partner with expanded capabilities in the United States and Europe. The company operates state-of-the-art facilities in Madrid, Spain, and recently acquired a major manufacturing site in Phoenix, Arizona, from Bristol Myers Squibb to bolster its sterile fill-finish and high-potency (cytotoxic) production capacity. ROIS is widely recognized for its strategic partnership with Moderna, serving as a primary fill-finish site for mRNA-based COVID-19 vaccines, and it continues to support global pharmaceutical leaders like Roche in the manufacture of next-generation metabolic and cardiovascular therapies. With a total network capacity exceeding 800 million sterile units per year, ROIS provides end-to-end services ranging from early-stage development to large-scale commercial supply.